Benign proliferative lesions mimicking recurrence of Hodgkin's disease
Ron Epelbaum(University of Bern), Nissim Haim(Technion – Israel Institute of Technology), Rachel Bar‐Shalom(Rambam Health Care Campus), Simona Ben‐Haim(Investigators Research Group (United States)), Michelle Leviov(Haifa Medical Center), Diana Gaitini(Technion – Israel Institute of Technology), Yehudit Ben-Arie(Technion – Israel Institute of Technology), Dov Front(Rambam Health Care Campus), Menachem Ben-Shahar(Technion – Israel Institute of Technology), Ora Israel(Technion – Israel Institute of Technology)
Medical and Pediatric Oncology
March 1, 1997
Cited by 8
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279